Decline depth
-53.9%
From rolling 252-day high of $13.22, 252d ago.
Past the 40% Red List threshold.
-53.9%
from rolling 252-day high of $13.22 set 2025-12-11 · 252d ago
Current
$6.09
Decline depth
-53.9%
Decline σ
4.4σ
TFC
5/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since tracking began
$RXST has been tracked since 2026-03-01. It was down 74.4% from its 52-week high then — now down -53.9%.
That's 4.5 percentage points deeper than the day it joined. It bottomed 84.5% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
RXST qualifies for the Red List on decline depth.
Time-frame continuity
5/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Full bearish continuity — every time frame is broken.
Decline sigma
4.4σ
Drop from local high over the last 10 bars, expressed in units of the stock's typical daily volatility (4.01% per day).
Past the ≥4σ Watch threshold.
The structural read
What price action says about RXST.
RXST qualifies for the Red List on decline depth — down -53.9% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.
Cross-confirmation: also showing 5/5 bearish time frames.
Cross-confirmation: decline sigma also reads 4.4σ over 10 bars.
Earnings on file: 2026-08-05. Tiering is unaffected by earnings dates — listings reflect price structure only.
Questions about RXST
What people ask.
Why is RXST on Broken Stocks?
RXST qualifies for the Red List on decline depth. It is down -53.9% from its rolling 252-day high of $13.22, set on 2025-12-11 — 252d ago.
Is RXST a falling knife?
Not by the strict technical definition. RXST is down -53.9% from its 52-week high, but that high was set 252d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. RXST is still on the Red List for decline depth, but the freshness component of a falling knife is missing.
Is RXST a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is RXST trading inside its 52-week range?
At $6.09, RXST sits 18.4% of the way from its 52-week low ($4.48) to its 52-week high ($13.22). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has RXST been declining?
The current 53.9% decline accrued over 252d, which annualizes to roughly -78.1% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does RXST compare to its sector?
There are 143 other Healthcare tickers on Broken Stocks: 69 Red, 35 Amber, 39 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — RXST's decline is deeper than the sector median.
Does RXST's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-08-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.